Live Breaking News & Updates on Replicel Life Sciences

Stay updated with breaking news from Replicel life sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

RepliCel Life Sciences Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CAD 0.311734 million compared to CAD 0.743228. ....

Replicel Life Sciences Inc , Replicel Life Sciences ,

RepliCel Life Sciences : Announces Secured Loan Agreement

RepliCel Announces Secured Loan Agreement

VANCOUVER, BC, CANADA -April 17, 2024 - RepliCel Life Sciences Inc. , a company developing next-generation technologies in. ....

United States , United Kingdom , Hong Kong , British Columbia , Andrew Schutte , Mainpointe Pharmaceuticals , Bc Ltd , Replicel Life Sciences Inc , Replicel Life Sciences , Canadian Securities Exchange , China Health Company , Replicel Announces Secured Loan , Cel Life Sciences , Chief Executive Officer , Multilateral Instrument , Minority Security Holders , Special Transactions , Canadian Securities , Loan Agreement , Greater China ,

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -November 30, 2023 at 01:09 pm EST

REPLICEL LIFE SCIENCES INC.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the six months ended September 30, 2023 and 2022

. ....

United States , British Columbia , Hong Kong , Lee Buckler , David Hall , Replicel Life Sciences Inc , Company Stock Option Plan , Company Or Replicel , International Financial Reporting Standards , Shiseido Company , Company Options , Venture Exchange , Party Transactions , Bus Partnership , Trichoscience Innovations Inc , International Accounting Standards Board , Mainpointe Pharmaceuticals , Technology Transfer Agreement , China Health Industry Co , While The Company , National Instrument , Given The Company , Canadian Dollars , Interim Financial , Consolidated Interim Statements , Cel Life Sciences ,

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -October 24, 2023 at 11:14 am EDT

REPLICEL LIFE SCIENCES INC.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the six months ended June 30, 2023 and 2022

. ....

British Columbia , Hong Kong , United States , Lee Buckler , David Hall , Party Transactions , Bus Partnership , Venture Exchange , Trichoscience Innovations Inc , International Financial Reporting Standards , Company Options , Shiseido Company , China Health Industry Co , Replicel Life Sciences Inc , Mainpointe Pharmaceuticals , International Accounting Standards Board , Company Stock Option Plan , Technology Transfer Agreement , While The Company , Company Or Replicel , National Instrument , Given The Company , Canadian Dollars , Interim Financial , Consolidated Interim Statements , Cel Life Sciences ,

Innovate BC Awards $1.365M to B.C. R&D Projects Solving

Innovations in natural resources and applied sciences with the potential to change the world. ....

British Columbia , Province Of British Columbia , United Kingdom , Behraad Bahreyni , Mohsen Akbari , Alexandre Brolo , Laurel Schafer , Brenda Bailey , Adam Clare , Tomica Divic , Life Sciences , Rapidia Tech Inc , Simon Fraser University , Voxcell Bioinnovation Inc , University Of Victoria , O Advanced Materials Inc , University Of British Columbia , Replicel Life Sciences Inc , A Crown Agency Of British Columbia , Endowment Fund , Kite Company Creator , Economic Development , Advanced Materials , Advanced Health , Voxcell Bioinnovation , Kite Company Creator Limited ,